New Study: Consumers Self-Medicate With Cannabis to Treat Anxiety, Pain, and Depression
QUEBEC–According to statistics found in the Journal of Cannabis Research, the most common reasons Canadians use cannabis for self-medication are to treat pain, anxiety, insomnia, and depression.489 people who admitted to buying cannabis products at adult-use stores for self-medicating were interviewed by Canadian researchers. According to previous research, respondents were most likely to say they used cannabis products to reduce anxiety (70 percent), enhance sleep (56 percent), relieve pain (53 percent), and deal with depressive symptoms (37 percent). Additionally, subjects were more likely to admit to using cannabis to treat their post-traumatic stress symptoms, migraines, and muscle stiffness.
Most survey participants said they used cannabis flower and chose THC-rich products. However, those who simply indicated that they used cannabis for medical purposes demonstrated a preference for goods with a high CBD content.
In contrast to past polls, the majority of respondents admitted telling their medical practitioners they used cannabis.
Similar findings from a different recent poll were reported in the journal Complementary Therapies in Clinical Practice, which found that most Americans with medical cannabis cards use it to alleviate pain, anxiety, post-traumatic stress disorder, and depression symptoms. Another recent survey by Harris Polling revealed that users most frequently claim to use cannabis to lower stress, enhance sleep, and lessen anxiety.
According to separate survey information obtained in April, 21% of US Medicare users admit to using cannabis for therapeutic purposes, usually to treat symptoms of chronic pain, anxiety, and depression.
The Journal of Cannabis Research has published the complete article, “A Description of Self-Medication with Cannabis Among Adults With Legal Access to Cannabis in Quebec, Canada.”
Latest News
Acreage Introduces Fast-Acting Gummies to The Botanist Offerings
NEW YORK - Acreage Holdings, Inc. (CSE: ACRG.A.U, ACRG.B.U), (OTC: ACRHF, ACRDF), a multi-state operator of cannabis cultivation and retailing facilities in the U.S., announced the launch of “Fast-Acting Gummies” or “TiME Gummies” under its ...
CBD Gummies Market Size Growth Forecasts at 28.3% of CAGR during 2021 to 2028
New York - According to The Insight Partners, “CBD Gummies Market Size, Share, Growth, Trends and Global Forecast to 2028 - COVID-19 Impact and Global Analysis By Category (Sugar-Free and Conventional) and Distribution Channel (Specialty ...
Gold Flora Expands Jetfuel Cannabis Brand in California
COSTA MESA, Calif. - Gold Flora, a single-state cannabis company, announced the launch of the Jetfuel Cannabis brand of products throughout California, beginning with the introduction of strain-specific cured resin cartridges. Jetfuel has gained a ...